$1.12 Billion is the total value of Rhenman & Partners Asset Management AB's 82 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 52.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HZNP | Sell | HORIZON THERAPEUTICS PUB LTD | $53,988,000 | +29.5% | 695,000 | -7.3% | 4.80% | +6.6% |
| VRTX | Sell | VERTEX PHARMACEUTICALS INC | $29,933,000 | -25.0% | 110,000 | -20.0% | 2.66% | -38.3% |
| ABBV | Sell | ABBVIE INC | $24,525,000 | -16.7% | 280,000 | -6.7% | 2.18% | -31.5% |
| AXNX | Sell | AXONICS MODULATION TECH INC | $23,478,000 | +42.3% | 460,000 | -2.1% | 2.09% | +17.1% |
| IMMU | Sell | IMMUNOMEDICS INC | $18,821,000 | +15.5% | 221,351 | -51.9% | 1.67% | -5.0% |
| BMY | Sell | BRISTOL MYERS SQUIBB CO | $17,484,000 | -21.8% | 290,000 | -23.7% | 1.56% | -35.6% |
| XLRN | Sell | ACCELERON PHARMA INC | $16,317,000 | +10.5% | 145,000 | -6.5% | 1.45% | -9.0% |
| MGNX | Sell | MACROGENICS INC | $16,014,000 | -15.0% | 635,711 | -5.8% | 1.42% | -30.1% |
| SGEN | Sell | SEATTLE GENETICS INC | $13,698,000 | +7.5% | 70,000 | -6.7% | 1.22% | -11.5% |
| LIVN | Sell | LIVANOVA PLC | $9,494,000 | -10.3% | 210,000 | -4.5% | 0.84% | -26.2% |
| ISRG | Sell | INTUITIVE SURGICAL INC | $8,514,000 | -12.1% | 12,000 | -29.4% | 0.76% | -27.7% |
| AMRN | Sell | AMARIN CORP PLCspons adr new | $1,263,000 | -65.2% | 300,000 | -42.9% | 0.11% | -71.4% |
| HAL | Exit | HALLIBURTON CO | $0 | – | -8,299 | -100.0% | -0.01% | – |
| NLOK | Exit | NORTONLIFELOCK INC | $0 | – | -6,926 | -100.0% | -0.02% | – |
| WFC | Exit | WELLS FARGO CO NEW | $0 | – | -5,272 | -100.0% | -0.02% | – |
| BUD | Exit | ANHEUSER BUSCH INBEV SA/NVsponsored adr | $0 | – | -2,806 | -100.0% | -0.02% | – |
| PFE | Exit | PFIZER INC | $0 | – | -4,508 | -100.0% | -0.02% | – |
| DIS | Exit | DISNEY WALT CO | $0 | – | -1,338 | -100.0% | -0.02% | – |
| JPM | Exit | JPMORGAN CHASE & CO | $0 | – | -1,723 | -100.0% | -0.02% | – |
| JHG | Exit | JANUS HENDERSON GROUP PLC | $0 | – | -8,645 | -100.0% | -0.02% | – |
| IBM | Exit | INTERNATIONAL BUSINESS MACHS | $0 | – | -1,587 | -100.0% | -0.02% | – |
| XOM | Exit | EXXON MOBIL CORP | $0 | – | -5,388 | -100.0% | -0.03% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -120,000 | -100.0% | -0.43% | – |
| OMCL | Exit | OMNICELL INC | $0 | – | -60,000 | -100.0% | -0.46% | – |
| AIMT | Exit | AIMMUNE THERAPEUTICS INC | $0 | – | -285,000 | -100.0% | -0.51% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-10-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| UNITEDHEALTH GROUP INC | 40 | Q3 2023 | 4.0% |
| BIOMARIN PHARMACEUTICAL INC | 40 | Q3 2023 | 5.0% |
| ALKERMES PLC | 40 | Q3 2023 | 3.3% |
| LILLY ELI & CO | 39 | Q3 2023 | 5.8% |
| CVS HEALTH CORP | 39 | Q3 2023 | 3.5% |
| INTRA-CELLULAR THERAPIES INC | 39 | Q3 2023 | 2.4% |
| EDWARDS LIFESCIENCES CORP | 39 | Q3 2023 | 1.7% |
| VERTEX PHARMACEUTICALS INC | 38 | Q3 2023 | 4.3% |
| REVANCE THERAPEUTICS INC | 38 | Q3 2023 | 0.9% |
| ABBVIE INC | 37 | Q3 2023 | 4.4% |
View Rhenman & Partners Asset Management AB's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR/A | 2023-11-13 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-12 |
| 13F-HR | 2022-05-13 |
View Rhenman & Partners Asset Management AB's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.